Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-54.21M
↑ 24% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-71.41M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-54.21M | +33.2% |
| 2024 | $-81.11M | +43.4% |
| 2023 | $-143.31M | -27.5% |
| 2022 | $-112.38M | -54.2% |
| 2021 | $-72.88M | -160.2% |
| 2020 | $-28.01M | -250.4% |
| 2019 | $-7.99M | - |